In 2004, CellResearch stem cells scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date there are patents granted in multiple strategic key territories around the world.
The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy.
All cell strains are processed in the carefully supervised CellResearch cell culture facility to ensure you receive only the highest quality low passage cell strains for your research.
- Fibroblasts isolated from Normal Skin Adjacent to Keloid
- Fibroblasts isolated from Normal Skin Adjacent to Hypertrophic Scar
- Normal Skin Derived Cells
- Keloid Scar Derived Cell
- Hypertrophic Scar Derived Cells Culture
- Cod Lining Stem Cells
CellResearch Stem Cells Sales Enquiries
Call Banksia on 1300 769 944, +617 3902 3000, email or complete the below form.